ישראל - עברית - Ministry of Health

דיאסורין בע"מ - אחר - בתחומי אימונולוגינה ומיקרוביולוגיה in vitro ביצוע בדיקות אבחוניות

ישראל - עברית - Ministry of Health

sanofi israel ltd - plerixafor - תמיסה להזרקה - plerixafor 24 mg / 1.2 ml - plerixafor

ישראל - עברית - Ministry of Health

sanofi israel ltd - eliglustat - קפסולה קשיחה - eliglustat 84.4 mg - eliglustat

ישראל - עברית - Ministry of Health

sanofi israel ltd - vandetanib - טבליות מצופות פילם - vandetanib 100 mg - vandetanib

ישראל - עברית - Ministry of Health

sanofi israel ltd - avalglucosidase alpha - אבקה להכנת תמיסה מרוכזת לעירוי - avalglucosidase alpha 100 mg/vial - avalglucosidase alpha

ישראל - עברית - Ministry of Health

sanofi israel ltd - olipudase alfa - olipudase alfa 20 mg/vial - olipudase alfa

ישראל - עברית - Ministry of Health

sanofi israel ltd - sutimlimab - תמיסה לאינפוזיה - sutimlimab 50 mg / 1 ml - sutimlimab

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - pancreatin 60.12 mg - gastro resistant pellets - multienzymes (lipase, protease etc.) - pancreatic exocrine insufficiency.

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 50 mg/vial - enzymes - acute myocardial infarction in adults for the lysis of thrombi obstructing coronary arteries the improvement of ventricular function and reduction of the incidence of congestive heart failure. pulmonary embolism with hemodynamic deprivation. for fibrinolytic treatment of acute ischaemic stroke. treatment must be started within 3 hours of onset of the stroke symptoms and after prior exclusion of intracranial haemorrhage by means of appropriate imaging techniques.this treatment is restricted to a prescription by aspecialist in neurology.

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 20 mg/vial - enzymes - acute myocardial infarction: actilyse is indicated for use in the management of acute myocardial infarction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infarct size, the improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms. massive pulmonary embolism with hemodynamic deprivation : actilyse is indicated in the management of acute massive pulmonary embolism (pe) in adults : - for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and - for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatme